Viromed Medical AG (HAM:VMED) EBIT per Share : €-0.00 (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Viromed Medical AG EBIT per Share?

Viromed Medical AG's EBIT per Share for the six months ended in Jun. 2024 was €-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Viromed Medical AG's EBIT per Share or its related term are showing as below:

HAM:VMED's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 6.2
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Viromed Medical AG's EBIT for the six months ended in Jun. 2024 was €-0.15 Mil.

Viromed Medical AG EBIT per Share Historical Data

The historical data trend for Viromed Medical AG's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viromed Medical AG EBIT per Share Chart

Viromed Medical AG Annual Data

Trend

Dec21

Dec22

Dec23

EBIT per Share

-0.01

Viromed Medical AG Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial			-	-0.01	-0.01	-	-0.01

Viromed Medical AG EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Viromed Medical AG's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.109	/	20.250
=	-0.01

Viromed Medical AG's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.15	/	20.250
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.00

Viromed Medical AG (HAM:VMED) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Viromed Medical AG EBIT per Share Related Terms

Thank you for viewing the detailed overview of Viromed Medical AG's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Viromed Medical AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Viromed Medical AG (HAM:VMED) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

VMED:Germany

Address

Flensburger Str. 18, Pinneberg, SH, DEU, 25421

Website

https://www.viromed-medical-ag.de

Viromed Medical AG is engaged in developing medical devices. The company offers wound healing technology solutions.

Executives

Uwe Perbandt	Board of Directors
Katrin Kunstmann	Supervisory Board
Pd Dr. Markus Perbandt	Supervisory Board

Viromed Medical AG Headlines

No Headlines